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Age-related accumulation of T cells with markers
of relatively stronger autoreactivity leads to
functional erosion of T cells
Zohreh Tatari-Calderone1, Milica Stojakovic1,2, Ramita Dewan1, Gama Le Bouder1, Dragana Jankovic3 and
Stanislav Vukmanovic1,2,4*

Abstract
Background: Thymic involution is a prominent characteristic of an aging immune system. When thymic function is
reduced/absent, the peripheral T cell pool is subject to the laws of peripheral T cell homeostasis that favor survival/
expansion of T cell receptors with relatively higher functional avidity for self-peptide/MHC complexes. Due to
difficulties in assessing the TCR avidity in polyclonal population of T cells, it is currently not known whether high
avidity T cells preferentially survive in aging individuals, and what impact this might have on the function of the
immune system and development of autoimmune diseases.
Results: The phenotype of T cells from aged mice (18-24 months) indicating functional TCR avidity (CD3 and CD5
expression) correlates with the level of preserved thymic function. In mice with moderate thymic output (> 30% of
peripheral CD62Lhi T cells), T cells displayed CD3lowCD5hi phenotype characteristic for high functional avidity. In old
mice with drastically low numbers of CD62Lhi T cells reduced CD5 levels were found. After adult thymectomy, T
cells of young mice developed CD3lowCD5hi phenotype, followed by a CD3lowCD5low phenotype. Spleens of old
mice with the CD3low/CD5hi T cell phenotype displayed increased levels of IL-10 mRNA, and their T cells could be
induced to secrete IL-10 in vitro. In contrast, downmodulation of CD5 was accompanied with reduced IL-10
expression and impaired anti-CD3 induced proliferation. Irrespective of the CD3/CD5 phenotype, reduced severity
of experimental allergic myelitis occurred in old mice. In MTB TCRb transgenic mice that display globally elevated
TCR avidity for self peptide/MHC, identical change patterns occurred, only at an accelerated pace.
Conclusions: These findings suggest that age-associated dysfunctions of the immune system could in part be due
to functional erosion of T cells devised to protect the hosts from the prolonged exposure to T cells with highavidity for self.

Background
Immune system of elderly displays complex set of
changes relative to young individuals. Of the many variations observed, altered T cell function is the most consistent and most dramatic one [1]. Despite relatively normal
numbers of CD4+ and CD8+ lymphocytes, T-cell dependent functions of the immune system of aged individuals
are defective, as evidenced by reduced DTH reactions
and antibody production in response to vaccination and
infection [2]. This could be due to reduced proliferation
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of T cells, evident at biochemical level by defects in proximal TCR signaling cascade activation [3-5] and calcium
signaling [6], and at cellular level by defects in cytokine
production [7] and differentiation to Th1 or Th2 effector
cells [8]. In addition, the frequency of antigen-specific
naive T cells is reduced, due to an impaired production
of T cells caused by thymic involution [9]. Reduction of
the thymus size and cellularity generally starts in puberty
[10] and is thought to reflect depletion of thymic stromal
tissue [11], as well as thymus repopulation by bone marrow derived precursors [12].
The lower supply of naive T cells leads to a shift in
the balance between memory and naive T cells, with
overrepresentation of the former [3]. This is due to
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transitioning of the naive into the memory T cells following activation with antigen, but also in response to
the laws of T cell homeostasis. The peripheral T cell
pool is maintained by production of new T cells by the
thymus, and homeostasis-driven expansion of peripheral
T cells [13]. If the function of thymus is reduced, the
numbers of T cells are maintained by a compensatory
increase in homeostatic expansion [14,15]. The extent of
homeostatic expansion of any given T cell is dependent
on the functional avidity of the TCR for self-peptide/
MHC complexes [16-18]. One would therefore predict
that the peripheral repertoire of T cells would skew
towards high avidity T cells sometime following ageassociated thymic involution. This issue, however, has
not been addressed to date, due to difficulties in assessing the TCR avidity in polyclonal population of T cells.
T cells constantly tune their sensitivity to self-peptide/
MHC complexes by changing the levels of TCR/CD3
and CD5 molecules [19-21]. The letter is an inhibitor of
TCR signaling [22], and T cells perceiving strong signals
up-modulate CD5 to reduce signaling and avoid overstimulation. Similar impact is achieved by down-modulating CD3, producing a CD3loCD5hi phenotype. Converse phenotypic changes occur if surrounding signals
are perceived weak- T cells increase their sensitivity by
up-regulating CD3 levels and down-modulating CD5,
producing a CD3 hi CD5 lo phenotype. Thus, CD3 and
CD5 levels can serve as indicator of the strength of signal perception by T cells, and if the levels of self-peptide/MHC are constant, the major determinant of the
signal magnitude generated is the affinity/avidity of the
TCR for self-peptide/MHC complexes. Taking advantage
of the fact that levels of CD5 and TCR/CD3 expression
can be used to predict relative TCR avidity [21], we
have shown that relative levels of these two molecules
could be used as markers of overall avidity of the TCR
repertoire [23].
The avidity of TCR for antigen is considered an
important characteristic of an efficient T cell-mediated
immunity [24]. Protection against tumors or infectious
agents by monoclonal (or oligoclonal) T cell populations
correlates with the avidity of the TCR for given antigen
[25,26]. However, increase in the avidity to foreign antigens also elevates the avidity to self-peptide/MHC complexes [27], likely due to cross-reactivity between
cognate antigen and self-peptides that promote selection
and homeostasis of T cells [28]. As with foreign antigens, higher avidity for auto-antigens leads to more
severe autoimmunity [29-32]. Furthermore, high avidity
TCR engagement with self peptide/MHC molecules may
induce both cell intrinsic and extrinsic compensatory
mechanisms [33], rendering it impossible to predict the
net effect of high avidity TCR recognition on the function of a polyclonal immune system. We here show that
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CD3/CD5 phenotype of T cells undergoes a two-phase
change in aged, as well as mice subjected to adult thymectomy. Increased CD5 and reduced CD3 levels in the
first phase are consistent with preferential survival of
high-avidity T cells, while the second phase was characterized by a drop in CD5 levels. The latter change
appears to be a part of a shut-down of T cell function,
that followed a period with increased production of IL10. We speculate that this may be an attempt to counteract the preferential survival of high avidity T cells
due to their potential to induce stronger autoimmune
responses.

Results
Dynamics of peripheral T cell CD3 and CD5 levels in the
function of thymic export

To determine whether the level of thymic output in old
mice affects the functional avidity of the peripheral TCR
repertoire, we compared the levels of CD3 and CD5 cell
surface molecules on T cells of young (8-12 weeks old)
and old (18-24 months old) mice. Because of day-to-day
experimental variations and the use of antibodies conjugated to different fluorochromes, we calculated ratios of
mean fluorescence intensities (MFI) obtained in spleen
cells from paired old and young mice, as previously
described [23]. Significant (p < 0.0001) reduction of CD3
levels was observed in all old mice, while the levels of
CD5, although overall significantly (p = 0.0127) reduced,
were heterogenous (Figure 1A). These differences were
observed in both CD4+ and CD8+ T cells. Expression of
CD62L and CD44 were taken as indicators of preserved
thymic output in individual old mice (Figure 1B). These
parameters revealed a correlation between relatively wellpreserved thymic export (> 30% CD62Lhi cells) and the
upregulation of CD5 on peripheral T cells (Figure 1C).
The individual old mice carrying T cells with higher
levels of CD5 are herewith referred to as “type A”, while
the mice with T cells having lower levels of CD5 than the
control mice as “type B”.
Since the thymic function progressively declines with
age, development of “type A” likely precedes that of
“type B” phenotype. This, however, is difficult to verify
due to individual variations in the rate of thymic involution. To determine the sequence of phenotypes
directly, we performed adult thymectomy and followed
the phenotype of T cells. These results clearly indicated that the changes in the levels of CD5 expression
occur in two phases: phase with increased levels of
CD5 precedes the one with low CD5 levels (Figure
2A). The phenotypic switch occurred following a drastic reduction of T cells with naive phenotype similar to
the one seen in old mice (Figure 2B). In contrast to
the CD5, the levels of CD3 showed mild, but a progressive decline (Figure 2C).
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Figure 1 Changes of CD3 and CD5 levels in old mice. A) Spleen cells from young (8-12 weeks old) and old (12-24 months old) mice were
stained with anti-CD4-PE, anti-CD3-FITC and anti-CD5-APC, or anti-CD8-PE, anti-CD3-FITC and anti-CD5-APC antibodies and analyzed by flow
cytometry. Shown are ratios of CD3 or CD5 mean fluorescence intensities obtained on gated CD4+ or CD8+ spleen cells from matched old and
young individual mice. B) Spleen cells from the same set of mice were stained with anti-CD4-PE, anti-CD62L-FITC and anti-CD44-APC, or antiCD8-PE, anti-CD62L-FITC and anti-CD44-APC antibodies and analyzed by flow cytometry. Shown are % of CD62Lhi or CD44hi cells on gated CD4+
spleen cells. Similar results were seen in CD8+ T cells (data not shown). C) Dot plot showing relationship between %CD62Lhi cells found in
spleens of old mice and the ratio of CD5 mean fluorescence intensities (CD4+ T cells in old/CD4+ T cells in young mice). As a reference, the
value found in young mice is displayed as closed circle. Two cohorts, each consisting of 10 old mice were compared to two sets of 10 young
mice and cumulative data is shown. D) Shown are representative histograms of CD3, CD5, CD44, and CD62L staining on gated CD4+ T cells
analyzed in A-C, depicting the two patterns of CD5 expression that appear in old mice.

Distinct functional phenotypes of T cells from type A- or
type B- old mice

Lower levels of CD3 and higher levels of CD5 are indicators of high functional TCR avidity [21,23], and chronic
high-avidity TCR stimulation leads to production of IL10 [34-37]. We therefore sought to determine whether
aging immune system is prone to produce IL-10. IL-10
mRNA was significantly increased in the spleens of old
relative to young mice (Figure 3A). Stimulation of T cells
in vitro showed the propensity of young mice to respond
by IFNg production (Figure 3B), while T cells from type
A mice produced IL-10 (Figure 3C), as well as limited
amounts of IFNg. Interestingly, T cells from type B old
mice produced neither IFNg nor IL-10.

Reduced T cell responses of old mice in vitro and in vivo

Inability of type B old mice to produce IFNg suggested
that T cells from these mice may be hyporesponsive. To
test this possibility we evaluated proliferation of T cells
to anti-CD3 stimulation. As expected, the response was
dramatically reduced in type B, but not type A old mice
(Figure 4A). To evaluate whether aging affects T cell
responses to antigen in vivo, we induced experimental
allergic encephalomyelitis (EAE) and found that clinical
signs of the disease were significantly less severe in old
than in the young mice (Figure 4B), irrespective of
whether their T cells displayed type A or type B CD3/
CD5 phenotype after the end of the observation period
(data not shown). The reduced responses in old mice
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Figure 2 Changes of CD3 and CD5 levels following adult
thymectomy. A) Spleen cells from control and adult
thymectomized mice were stained with anti-CD4-PE, anti-CD3-FITC
and anti-CD5-APC, or anti-CD8-PE, anti-CD3-FITC and anti-CD5-APC
antibodies and analyzed by flow cytometry. Shown are ratios of
CD5 mean fluorescence intensities obtained on gated CD4+ or CD8
+
spleen cells from matched control and thymectomized individual
mice (four mice per group each time point). B) Spleen cells from
the same set of mice were stained with anti-CD4-PE, anti-CD62LFITC and anti-CD44-APC antibodies and analyzed by flow
cytometry. Shown are percent CD62Lhi or CD44hi cells on gated
CD4+ spleen cells. C) Shown are ratios of CD3 mean fluorescence
intensities obtained on gated CD4+ or CD8+ spleen cells from
matched control and thymectomized individual mice, stained as
described in (A)
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Figure 3 Age-dependent increase in IL-10 production. A) Total
cellular RNA isolated from the spleens of young and old mice was
used to obtain cDNAs which served as templates for the real time
PCR using IL-10-specific primers. Shown are means and standard
errors of IL-10 mRNA quantities relative to the 18S rRNA for
triplicate reactions of each sample for three individual mice per
group. B-C) Spleen cells from young or old mice (N = 3) were
stimulated with plate-bound anti-CD3 antibody. Following 3 day
culture, cells were stimulated with PMA/ionomycin and
supernatants were tested for interferon-g (B) or IL-10 (C) content by
ELISA. No IL-10 protein was detected in unstimulated control cells
(data not shown)
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Figure 4 Reduced T cell responsiveness in aged mice. A) AntiCD3-induced proliferation (means ± SD) of spleen cells from young
and old WT mice. Shown are values from individual mice from a
representative of four separate experiments. B) EAE was induced in
3 (closed symbols) or 16 (open symbols) months old female WT
mice. Shown are mean clinical scores of groups of ten mice each.
C) Spleen cells from young (8-12 weeks old) and old (12-24 months
old) mice were stained with anti-CD4 (extracellular stain) and antiFoxP3 (intracellular stain). Shown are mean (± SD) percentage of
FoxP3+ cells within gated CD4+ populations (upper panel), and
representative histograms for young (plain line) or old (bold line)
mice.

occurred in the presence of similar numbers of natural
regulatory T cells (Figure 4C). Thus, at least two distinct
mechanisms (propensity to secrete IL-10 in “type A” and
globally reduced responsiveness in “type B”) contribute
to reduced susceptibility of old mice to EAE.
Age related changes in T cells are accelerated in mice
with increased avidity for self

If the age-associated increased production of IL-10 and
subsequent crush in T cell function are a consequence
of preferential survival and/or homeostatic expansion of
T cells with high avidity for self, then the observed
changes should occur prematurely if the avidity of T
cells is artificially raised. MTB TCRb transgenic mice
display globally increased avidity for peptide/MHC complexes due to stronger interactions with MHC molecules
[23]. As previously reported, higher levels of CD5 with
fewer cell surface TCR/CD3 were found in MTB than in
WT mice (Figure 5A). The TCR/CD3 levels were
reduced despite about five fold higher levels of mRNA
encoding the constant region of TCRb (Figure 5B),
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Figure 5 Earlier onset of age dependent changes in CD3/CD5
phenotype and IL-10 induction in MTB mice. A) Spleen cells
from 7 week old WT or MTB mice were stained with anti-CD4-FITC,
anti-CD5-APC and anti-CD3-PerCP antibodies and analyzed by flow
cytometry. Shown are overlay histograms of CD5 or CD3 expression
in WT (plain line) and MTB (bold line) CD4+ cells. The numbers
indicate mean fluorescence intensities. B) cDNAs obtained from 12
weeks old MTB or WT spleens served as templates for real time PCR
using TCRb-specific primers. Shown are means and standard errors
of TCRb mRNA relative to the 18S rRNA for triplicate reactions of
each sample for two individual mice of each genotype. Total
cellular RNA isolated from the spleens of MTB or WT mice was used
to obtain cDNAs which served as templates for the real time PCR
using IL-10-specific primers. Shown are means and standard errors
of IL-10 mRNA quantities relative to the 18S rRNA for triplicate
reactions of each sample. D) CD5 or CD3 expression in 10 months
old WT (plain line) and MTB (bold line) CD4+ spleen cells labeled
with anti-CD4-FITC, anti-CD5-APC and anti-CD3-PerCP antibodies.
The numbers indicate mean fluorescence intensities.

arguing against the explanations related to the transgene
expression. As predicted, we found that increases in the
IL-10 mRNA peaked much earlier in MTB than in the
WT mice (Figure 5C). The subsequent decrease
occurred also earlier in MTB mice. This decrease in IL10mRNA levels was associated with a more pronounced
reduction of cell surface TCR/CD3 levels, and a reverse
trend in CD5 expression (Figure 5D).
As expected, changes in T cell phenotype and IL-10
mRNA levels in MTB mice coincided with reduced
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severity of EAE in 20 weeks old MTB mice relative to
their WT couterparts (Figure 6). In contrast, young
MTB mice (10 weeks old) developed a more severe
form and an earlier onset of the disease than the WT
mice. The stronger disease in young MTB mice
occurred despite relatively mild defect of in vitro T cell
responses to anti-CD3 stimulation (Figure 7A). This
finding is consistent with relatively higher avidity of
MTB T cells for self-peptide/MHC complexes. As the
MTB mice aged, the defect in anti-CD3 induced T cell
responses became more profound (Figure 7A), consistent with down-modulation of cell surface CD3.
Defective responses of T cells with down-modulated
CD5 could be a result of increased propensity for activation induced cell death. We therefore compared the
levels of apoptosis following anti-CD3 stimulation.
Reduced levels of apoptosis were observed in MTB relative to the WT T cells (Figure 7B), suggesting that activation induced cell death is not a likely cause of
reduced T cell responses in T cells with decreased CD5
levels.
To determine whether the hyporesponsiveness is due
to general inability of T cells to respond or due to TCR
signaling defect, we subjected T cells to pharmacologic
stimulation consisting of phorbol esters and ionomycin,
that by-passes the most proximal TCR signaling. The
results show relatively similar potential of cells to
respond to this stimulation (Figure 7C), suggesting that

Figure 7 Earlier onset of in vitro T-cell disfunction in MTB
mice. A) Anti-CD3-induced proliferation (means ± SD) of spleen
cells from 7 weeks (young) or 17 months old (old) WT or MTB mice.
B) Spleen cells from 20 weeks old MTB and WT mice were cultured
in the presence or absence of anti-CD3 antibody for 3 days.
Following subsequent 24 hour stimulation with anti-CD3, cells were
stained with anti-annexin V and propidium iodide. C) Proliferation to
PMA/ionomycin of purified T cells from 15 months old MTB or WT
mice in the presence of irradiated WT antigen presenting cells.

the cause of hyporesponsiveness is related to the CD3/
TCR complex-mediated signal transduction.

Figure 6 Earlier onset of age-associated reduced severity of
EAE in MTB mice. Mean clinical scores of EAE in MTB and WT mice
(five each) immunized at 10 or 20 weeks of age with MOG38-50
peptide.

Discussion
Our findings demonstrate that following a shortage in
supply of newly developed T cells due to thymic involution, peripheral T cell compartment in aged mice displays a sequence of phenotypic and functional changes
important for the functioning of the entire immune system. These changes follow a characteristic pattern. The
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first phase was predictable by the known effects of T
cell homeostasis in lymphopenic conditions and the
effect of the functional avidity of the TCR on peripheral
T cell homeostasis. In this phase, there was an increase
of both CD4 + and CD8 + T cells with a phenotype
(CD3lowCD5hi) indicative of relatively higher functional
avidity for self-peptide/MHC complexes [21]. The second phase is characterized by development of functional
erosion of T cells, caused by a defect in TCR-mediated
activation.
Self-peptide/MHC complexes are involved in many
aspects of T cell physiology, promoting thymocyte differentiation [38,39], enabling peripheral survival and
homeostasis of naïve T cells and modulating their activation by antigens [40-42]. Under lymphopenic conditions residual T cells proliferate to reconstitute their
nearly normal numbers [41]. T cells with higher avidity
for self-peptide/MHC complexes enjoy advantage and
expand more relative to the low avidity T cells [16-18].
During and or consequent to the expansion process T
cells acquire phenotype of activated/memory T cells and
acquire effector functions [43-47]. In addition to the faster disappearance of T cells with naive phenotype, the
accumulation of high avidity T cells and their partial
activation is potentially dangerous due to increased risk
of autoimmune disorders. In fact, lymphopenic conditions are known to be associated with autoimmune phenomena [48]. However, the incidence of autoimmune
diseases in general does not increase in elderly, despite
development of lymphopenia.
In humans, each autoimmune disease has a characteristic pattern of incidence. Although average peak of incidence differs for each individual autoimmune disease, a
general trend suggests that most autoimmune diseases
develop either during puberty (juvenile type diseases) or
during mature reproductive life of individuals. For
example, lupus erythematosus affects primarily women
of childbearing age, and most frequently begins between
ages of 15 and 40 years [49]. The average age of onset
of multiple sclerosis is 28-30 years [50]. The number of
new cases in both diseases, as well as other autoimmune
diseases, reduces with further age. What could be the
reason for this decline? The function of the immune
system declines with aging in both mice and humans,
limiting its ability to respond to infections and vaccines
[2,15]. The changes are mainly due to dysfunctions in
the T cell compartment while the activity of B cells and
innate immunity are less affected [2,51]. However, these
changes occur at age of 70 or higher, and are unlikely
responsible for the decline in incidence of autoimmunity
after the ages of 30-40. Our results showing attenuated
clinical EAE in aged mice are in agreement with the
incidence of human autoimmune disorders. Concomitant changes in T cell phenotype and function of old
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mice suggest that reasons for reduced autoimmunity
may be intrinsic to T cells. This notion is further supported by an earlier occurrence of EAE attenuation in
MTB TCRb transgenic mice, since the transgene is
expressed by T cells and hence affects primarily the
function of T cells. Interestingly, we have previously
shown an age-dependent arrest in the progression of
lupus in F1 offsprings of MTB and lupus-prone BXSB
strain [52]. This arrest was coupled with reduced activation of T cells in vivo and reduced numbers of natural
regulatory T cells, suggesting again a mechanism intrinsic to T cells. The numbers and function of natural regulatory T cells in MTB mice on B6 background (used in
the present study) are indistinguishable from the WT
mice [23], arguing against the role of these cells in
reduced susceptibility of MTB mice to EAE. It remains
to be determined whether intrinsic mechanisms additional to the two identified here (increased IL-10 production and functional arrest) may be involved, such as
possibly changes in IL-17 production- a cytokine important for development of EAE [53].
It is tempting to speculate that the strategy of the
immune system to counteract age associated increased
risk of autoimmunity is promotion of differentiation of
T cells with a potential to secrete IL-10 (so called Tr1
cells). In support of this notion, development of multiple
sclerosis in humans is associated with defective development of Tr1 cells that secrete IL-10 [54,55]. IL-10 secretion as a result of chronic high-avidity TCR engagement
has been described in other experimental models
[34-37], and increased IL-10 production associated with
aging has been reported in both aged mice [56] and
humans [51]. Our results showing an earlier onset of IL10 mRNA levels in mice with artificially higher TCR
avidity for self-peptide/MHC complexes clearly supports
this possibility, although this may not be the only
mechanism affecting the function of the immune system
in type A mice. Subsequent reduction, however, suggests
that the control of enhanced T cell reactivity for self by
IL-10 is temporary, and persisting chronic stimulation
leads to a functional shut down.
Because IL-10-deficient mice develop enterocolitis
[57], IL-10 is thought to be involved in maintenance of
tolerance to self. However, IL-10 can also exert immunostimulatory properties, such as stimulation of B cell
proliferation and differentiation into the antibody-secreting cells, and differentiation of CD8+ T cells into effector cells [58]. Despite these stimulatory functions of IL10, the effect of IL-10 in most studies of autoimmune
diseases is one of regulation. Thus in EAE, systemic
administration of IL-10 prior to EAE induction prevents
the development of the disease [59,60]. In contrast to
the actively induced EAE, injection of IL-10 exacerbated
adoptively transferred form of the disease [61]. Removal
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of IL-10 by gene inactivation increases the severity of
the disease [62-64], suggesting that IL-10-production
has a physiological role in dampening the course of the
EAE. In lupus, the levels of IL-10 found in the serum of
affected patients correlate with the disease activity [65].
This could suggest involvement of IL-10 in the pathogenesis of the disease, but also (apparently unsuccessful)
attempts of the immune system to regulate the ongoing
autoimmune response. The former possibility is supported by ameliorating effects of anti-IL-10 antibody
treatment in lupus patients [66], as well as in NZB
hybrid mice [67]. However, these early results were
countered with the findings of new studies. Thus,
genetic deficiency of IL-10 resulted in significantly
enhanced disease, while the treatment with recombinant
IL-10 ameliorated the disease in the MRL model [68].
Furthermore, continuous low levels of IL-10 achieved by
gene therapy approach also diminished the disease activity in NZB hybrid congenic mouse model [69]. Therefore, the exact role of IL-10 in lupus remains to be
established.
T cell dysfunction resulting in progressive difficulties
to raise immune responses have been described in
elderly humans and mice [15,70]. Therefore, these findings suggest that T cell dysfunctions associated with
aging can at least partly be explained by adaptive alterations in high-avidity T cells caused by their autoreactivity. Our findings parallel those of tumor infiltrating T
cells that become non-functional if their TCR is of high,
but not low affinity for antigen [71]. Thus, while their
immediate impact may be effective, high avidity T cells
may not be most desirable for long-term protection
and/or preservation of immunological memory, as they
are likely to functionally erode earlier than the low avidity T cells.

Conclusions
T cell function deteriorates with age, leading to
increased susceptibility of elderly to infections and
higher incidence of cancer. We demonstrate that following arrest of thymic export (either due to aging or adult
thymectomy), T cells undergo a two-phase change in
the expression of CD3 and CD5 molecules. Initial
increase in CD5 and decrease in CD3 levels are consistent with preferential peripheral survival of T cells with
relatively high avidity for self. These cells are prone for
production of IL-10. Subsequently, the T cells reduce
the levels of CD5 and become generally unresponsive
(including the IL-10 production). Through both phases
mice display reduced severity of an autoimmune disease
EAE. These findings suggest that age-associated dysfunctions of the immune system could in part be due to
functional erosion of T cells devised to protect the hosts
from autoreactivity induced by T cells with high-avidity
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for self, that preferentially survive in mice with reduced
thymic function (Figure 8).

Methods
Mice and in vivo manipulations

C57BL/6 mice were purchased from Taconic Farms
(Germantown, NY). The generation of MTB TCRb
transgenic mice has been previously described [72]. All
experiments using laboratory animals have been
approved by the Institutional Animal Care and Use
Committee.
For induction of EAE five mice per group were
injected with an emulsion of MOG 38-50 peptide ([73]
solution in Complete Freund’s adjuvant containing
Mycobacterium tuberculosis, as described [74]. Mice also
received 500 ng Pertussis toxin on days 0 and 2 relative
to the encephalitogenic challenge. Mice were followed
daily for clinical signs of the disease and were graded on
the following basis: 0) no clinical signs; 1) flaccid tail; 2)
hind limb paresis or partial paralysis; 3) total hind limb
paralysis; 4) hind and front limb paralysis; and 5) moribund state or death.
Quantitative PCR

Total RNA was isolated from cells using TRIzol followed by RNAse clean-up and treatment with DNAse I.
Total RNA was reverse transcribed using the Superscript II RT kit and random hexamers as primers (Invitrogen, Carlsbad, CA). All PCR reactions were done in
triplicates using ABI Prism 7700 Sequence Detector
(Applied Biosystems, Piscataway, NJ), as previously
described [23]. Briefly, TCRb, IL-10, and 18SrRNA were
amplified using TaqMan Universal PCR master mix
(Applied Biosystems). The average threshold cycles (Ct)
of the triplicates was used to compare the relative abundance of the mRNA. Ct of 18SrRNA was used to normalize all samples.

Figure 8 Summary and implications of the findings in the
present manuscript.
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Flow cytometry

Statistical analysis

Direct immunofluorescence staining was performed
using following reagents: FITC conjugated anti-Vb2,
FITC- or APC-conjugated anti-CD5, FITC- or APCconjugated anti-CD4, PerCP-conjugated anti-CD3, PEconjugated anti-mouse CD8a, PE-conjugated anti-CD25
(all supplied by Pharmingen, San Diego, CA).

Statistical significance of differences in the mean fluorescence intensities of CD5 and CD3 staining was calculated using Wilcoxon matched pairs test, performed
using Graphpad Prism software, version 5.0a.
Abbreviations
EAE: Experimental allergic encephalomyelitis

Cell purification

Spleen cells were purified using pan T cell purification
kit (Miltenyi Biotec, Bergisch Gladbach, Germany).
Microbead labeled cells were negatively selected on
magnetic cell separation (MACS) columns (Miltenyi
Biotec), as per manufacturer instructions. Cell purity
was generally 92-97%, as determined by flow cytometry.
Intracellular staining for FoxP3 was performed using the
anti-mouse/rat FoxP3 staining kit from eBioscience (San
Diego, CA).
In vitro stimulation assays

Spleen cells (2 × 105/well) were incubated for 72 hours
in flat bottom 96-well plates in the presence of various
concentrations of purified anti-CD3 monoclonal antibody. Irradiated (2500 rads) WT spleen cells served as
antigen presenting cells in cultures with thymocytes (5
× 105/well), where indicated. During the last 8-16 hours
of culture cells were pulsed with 0.5 μCi of 3H-thymidine (ICN Biomedicals, Costa Mesa, CA, USA) and thymidine incorporation was subsequently measured using
a beta scintillation counter 1450 MicroBetaTM (Wallac,
Turku, Finland).
AICD analysis

T lymphocytes from WT or MTB TCR transgenic
mice were isolated from the spleen by negative selection (Pan T Cell Isolation Kit, Miltenyi Biotec). T cells
(10 6 /ml) were stimulated in vitro using CD3/CD28
beads (Dynabeads mouse CD3/CD28 T cell expander,
Invitrogen) according to the manufacture’s instruction.
After 3 days, T cells were harvested and dead cells
were removed by using gradient centrifugation. Viable
T cells were then incubated for an additional 24 h
with 10 U/ml recombinant mouse IL-2. For the secondary culture, T cells (5 × 105/ml) were restimulated
with anti mouse CD3 beads. Cells were then harvested
and stained with Annexin-FITC and Propidium IodidePE using Annexin V-FITC apoptosis detection kit II
(BD Biosciences) and CD4-allophycocyanin (BD Biosciences) according to the manufacturer’s instructions.
Analysis was based on a CD4 cell gate. Data were collected on a FACSCalibur (BD Biosciences) and analyzed using CellQuest software.
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